

Senvelgo oral solution
Senvelgo oral solution by Boehringer Ingelheim is a veterinary-prescribed medication formulated to help reduce hyperglycemia in cats with non-insulin dependent diabetes mellitus. This easy-to-administer oral solution contains velagliflozin L-proline monohydrate at 15 mg/mL. Available in 12 ml and 30 ml bottles (DIN 02543427), it supports veterinarian-directed diabetes management for cats. For use only under the guidance of a veterinarian; prescription required in Canada.
Original: $102.04
-65%$102.04
$35.71Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Senvelgo oral solution by Boehringer Ingelheim is a veterinary-prescribed medication formulated to help reduce hyperglycemia in cats with non-insulin dependent diabetes mellitus. This easy-to-administer oral solution contains velagliflozin L-proline monohydrate at 15 mg/mL. Available in 12 ml and 30 ml bottles (DIN 02543427), it supports veterinarian-directed diabetes management for cats. For use only under the guidance of a veterinarian; prescription required in Canada.


















